Illumina director-linked fund to sell $67M in stock
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ILLUMINA, INC. (ILMN) is the issuer of common stock that an investment fund advised by Corvex Management, an affiliate of an Illumina director, plans to sell under Rule 144. The planned sale covers 300,000 shares of common stock, with an aggregate market value of $66,966,000.00, to be executed through Goldman Sachs & Co. LLC. Illumina reports 151,000,000 shares outstanding of this class as of the notice, which is a baseline figure, not the amount being sold.
Corvex-linked entities have reported multiple sales of Illumina common stock in the past three months, including 220,000 shares on May 28, 2026 for $34,686,783.32 and 457,858 shares on August 4, 2026 for $91,616,949.73. The shares now to be sold were purchased in various open market transactions between October 25, 2023 and March 27, 2025.
Key Figures
Key Terms
Rule 144 regulatory
beneficial owner financial
aggregate market value financial
open market transactions market
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is ILMN’s Rule 144 sale reported by Corvex Management?
What recent ILMN stock sales has Corvex reported in the past three months?
What is the relationship between Corvex Management and ILMN?
AI-generated analysis. How Rhea-AI works. Not financial advice.